https://www.zacks.com/stock/news/2230820/exploring-analyst-estimates-for-pure-storage-pstg-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230820
Feb 23, 2024 - Evaluate the expected performance of Pure Storage (PSTG) for the quarter ended January 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zc:-4501802740283552259
0
https://www.zacks.com/stock/news/2230836/exploring-analyst-estimates-for-jazz-jazz-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230836
Feb 23, 2024 - Besides Wall Street's top -and-bottom-line estimates for Jazz (JAZZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
zc:4358863407234356550
0
https://www.zacks.com/stock/news/2230842/exploring-analyst-estimates-for-amc-entertainment-amc-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230842
Feb 23, 2024 - Evaluate the expected performance of AMC Entertainment (AMC) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
zc:1194658228737919670
0
https://seekingalpha.com/news/4069362-gatos-silver-gaap-eps-of-018-revenue-of-7351m-issues-fy24-production-and-cost-guidance?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Feb 20, 2024 - Gatos Silver press release (GATO): Q4 GAAP EPS of $0.18.
Revenue of $73.51M (-20.9% Y/Y).
LGJV Q4 2023 revenue of $73.5 million, down 21% from $93.0 million.
EBITDA $38.6 million,
0
sa:-2934284820633526482
0
https://www.zacks.com/stock/news/2227839/exploring-analyst-estimates-for-ryman-hospitality-properties-rhp-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2227839
Feb 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Ryman Hospitality Properties (RHP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:-6302239569070789692
0
https://www.zacks.com/stock/news/2227871/countdown-to-live-nation-lyv-q4-earnings-a-look-at-estimates-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2227871
Feb 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Live Nation (LYV), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:4331461119467489543
0
https://www.zacks.com/stock/news/2227452/otis-provides-medium-term-guidance-for-sales-eps-shares-up?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2227452
Feb 16, 2024 - OTIS is set to achieve its medium-term outlook on the back of operational improvements.
zc:-6567376975282169866
0
https://www.zacks.com/stock/news/2225407/exploring-analyst-estimates-for-american-axle-axl-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2225407
Feb 13, 2024 - Looking beyond Wall Street's top -and-bottom-line estimate forecasts for American Axle (AXL), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2023.
zc:-5584598466200085660
0
https://www.zacks.com/stock/news/2224643/exploring-analyst-estimates-for-louisiana-pacific-lpx-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224643
Feb 12, 2024 - Besides Wall Street's top -and-bottom-line estimates for Louisiana-Pacific (LPX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
zc:4254251580450829570
0
https://www.zacks.com/stock/news/2224661/exploring-analyst-estimates-for-adaptive-biotechnologies-adpt-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224661
Feb 12, 2024 - Beyond analysts' top -and-bottom-line estimates for Adaptive Biotechnologies (ADPT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
zc:-9053884170122770803
0